Drug – bio-affecting and body treating compositions – Inorganic active ingredient containing – Heavy metal or compound thereof
Reexamination Certificate
2007-03-20
2007-03-20
Richter, Johann (Department: 1616)
Drug, bio-affecting and body treating compositions
Inorganic active ingredient containing
Heavy metal or compound thereof
C424S715000, C514S891000
Reexamination Certificate
active
10128783
ABSTRACT:
Conditions such as kidney stones, which are characterized by undesired absorption of oxalate from the intestinal tract are conveniently treated using nontoxic salts of rare earth metal ions.
REFERENCES:
patent: 5951958 (1999-09-01), Kimura
patent: 5968976 (1999-10-01), Murrer et al.
patent: 6200562 (2001-03-01), Allison et al.
patent: 6355242 (2002-03-01), Allison et al.
patent: 1668562 (1971-09-01), None
patent: 3046580 (1982-07-01), None
patent: 3213139 (1983-10-01), None
patent: 61-004528 (1986-01-01), None
patent: 62145024 (1987-06-01), None
patent: 2061040 (1996-05-01), None
patent: WO 96/30029 (1996-10-01), None
patent: WO 98/52586 (1998-11-01), None
patent: WO 99/22744 (1999-05-01), None
PUBMED online, file MEDLINE, PMID 10421978 (Fallingborg, “Intraluminal pH of the human gastrointestinal tract”, Dan. Med. Bull. (1999), vol. 43, No. 3, pp. 183-196), Abstract.
Bailar et al., eds., Comprehensive Inorganic Chemistry (1973), pp. 82,93,94.
STN/CAS online, file CAPLUS, Acc. No. 1968:492507, Doc. No. 69:92507 (Pajakoff,“Phosphates and phosphato complexes of rare earth metals”, Monatshefte fuer Chemie (1968), vol. 99, No. 4, pp. 1400-1408), Abstract.
Pajakoff,“Phosphates and phosphato complexes of rare earth metals”, Monatshefte für Chemie (1968), vol. 99, No. 4, pp. 1400-1408.
File MEDLINE on PUBMED online, Doc. No. 8441076 (Elton et al., A clinical prediction rule of the diagnosis of ureteral calculi in emergency departments, J. Gen. Intern. Med. (1993), vol. 8, No. 2, pp. 57-62), Abstract.
File MEDLINE on PUBMED online, Doc. No. 2692048 (Frank et al., Urolithiasis in primary care, Prim. Care (1989), vol. 16, No. 4, pp. 967-980), Abstract.
File MEDLINE on PUBMED online, Doc. No. 3993484 (Ebisuno et al., [Studies of urinary risk factors in urolithiasis], Hinyokika Kiyo (1985), vol. 31, No. 1, pp. 1-15), Abstract.
File MEDLINE on PUBMED online, Doc. No. 37975 (Roberson et al., Risk factors in calcium stone disease of the urinary tract, Br. J. Urol. (1978, vol. 50, No. 7, pp. 449-454), Abstract.
Grases et al. (1999).International Urology and Nephrology31(5):591-600.
Holmes, R. et al. (2001).Kidney International59:270-276.
Reginato, A.J. et al. (1989).Semin Arthiritis Rheum18:198.
European Search Report, Appl. No. EP 02 76 4336, dated Jun. 2, 2004.
Absract, Dewberry et al., “Lanthanum Carbonate An Effective Inhibitor Of Phosphate Absorption From The Intestinal Track” Nephrology Dialysis Transplantation, Oxford University Press, GB, vol. 12, No. 9, 1997, p. A98, XP009030453.
Abstract, Hutchison, A.J. et al., “Lanthanum Carabonate: A Novel Non-Calcaemic Phosphate Binder In Dialysis Patients” Nephrology Dialysis Transplantation, Oxford University Press, GB, vol. 15, No. 9, Sep. 2000 (2000-09), p. A113, XP009014903.
Locatelli F. et al., “Lanthanum Carbonate Anormed” Current Opinion In Cardiovascular Pulmonary And Renal Investigational Drugs, Current Drugs, London, GB vol. 2, 2000, pp. 372-377, XP009030303.
Harris A.F., et al., “The Effect Of Lanthanum Chloride And Related Compounds On Calcification” Archives Internationales De Pharmacodynamie Et. De. Therapie, Heymans Institue Of Pharmacology, Ghent, BE, vol. 186, Aug. 1970 (1970-08), pp. 269-278, Xp000912133.
Hutchison A.J., “Calcitriol, Lanthanum Carbonate, And Other New Phosphate Binders In The Management Of Renal Osteodystrophy”, Peritoneal Dialysis International, Pergamon Press, New York, NY, US, vol. 19, No. Suppl. 2, 1999, pp. S408-S412, XP009030319.
Y.Y. Lurji Analytical chemisty reference book:, M. “Khimia”, 1989, pp. 322-323.
Russian Official Action for Appl. No. 2003133991/14(036768) dated Feb. 1, 2006.
Abrams Michael J.
Bridger Gary J.
Fricker Simon P.
Idzan Stefan R.
Choi Frank
Richter Johann
Shire International Licensing B.V.
LandOfFree
Use of rare earth compounds for the prevention of kidney... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of rare earth compounds for the prevention of kidney..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of rare earth compounds for the prevention of kidney... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3775793